XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Stock-Based Compensation  
Schedule of stock option activity under the Equity Plans

Weighted

    

    

Average

    

Weighted

    

Aggregate

 

Exercise Price

 

Average Remaining

 

Intrinsic

Options

 

Per Share

Life in Years

Value

Outstanding at December 31, 2020

6,393,853

5.29

7.96

1,961

Granted

 

2,482,650

2.19

 

  

  

Exercised

 

(2,292)

1.55

 

Forfeited

(348,593)

3.17

Outstanding at December 31, 2021

 

8,525,618

4.48

 

7.58

7,673

Granted

 

4,024,900

1.50

 

  

  

Forfeited

(633,187)

2.17

Outstanding at December 31, 2022

11,917,331

3.59

7.47

Options exercisable at December 31, 2022

 

7,543,973

4.74

 

6.46

Options vested and expected to vest at December 31, 2022

 

11,917,331

3.59

 

7.47

Schedule of assumptions used to determine grant-date fair value of stock options

Year Ended December 31, 

    

2022

    

2021

Expected volatility

 

82.70

%

67.64

%

Weighted average risk-free interest rate

 

3.10

%

0.82

%

Expected dividend yield

0.00

%

0.00

%

Expected term (in years)

6.42

6.82

Schedule of RSU activity under the 2016 Plan

 

Weighted

    

Number of

    

Average Grant

 

Shares

 

Date Fair Value

Outstanding at December 31, 2020

 

753,106

$

1.52

Awarded

275,000

$

2.57

Settled in cash

(92,500)

$

1.97

Outstanding at December 31, 2021

935,606

$

1.76

Awarded

 

2,650,000

$

1.94

Outstanding at December 31, 2022

 

3,585,606

$

1.89

Schedule of recognized stock-based compensation expense related to the issuance of stock option awards and RSUs to employees and non-employees in the condensed consolidated statements of operations

Year Ended

December 31, 

    

2022

    

2021

Research and development

 

$

2,540

$

1,641

General and administrative

 

2,640

 

2,045

Total

$

5,180

$

3,686